Featured Research

from universities, journals, and other organizations

Largest Review Of Its Kind Associates Anti-inflammatory Drugs With Reduced Breast Cancer Risk

Date:
October 8, 2008
Source:
University of British Columbia
Summary:
Analysis of data from 38 studies that enrolled more than 2.7 million women -- the largest of its kind -- reveals that regular use of nonsteroidal anti-inflammatory drugs is associated with a 12 per cent relative risk reduction in breast cancer compared to nonusers.

Analysis of data from 38 studies that enrolled more than 2.7 million women – the largest of its kind – by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.

A separate analysis for Aspirin showed a 13 per cent relative risk reduction in breast cancer and an analysis for Advil showed a 21 per cent relative risk reduction.

The review, published in the U.S. Journal of the National Cancer Institute, alludes to a protective affect against breast cancer. It was conducted by Dr. Mahyar Etminan, assistant professor of medicine at the University of British Columbia, and member of the Vancouver Coastal Health Research Institute, and Bahi Takkouche, professor of epidemiology at the University of Santiago de Compostela in Spain.

Previous studies have shown conflicting results that support and fail to support the use of non-steroidal anti-inflammatory drugs (NSAIDs), including Aspirin and ibuprofen (Advil), in reducing the risk of developing breast cancer.

Etminan cautions that since most of the data is from observational studies, the results should be considered as hypothesis generating.

"The results are encouraging and may help us better understand the importance of role of inflammation in the pathology of the disease," says Etminan, who is also a scientist at the Center for Clinical Epidemiology and Evaluation at VCHRI. "However, we don't recommend the routine use of NSAIDs for breast cancer prevention until large randomized trials confirm these findings. Results from an ongoing trial will be available in 2009."


Story Source:

The above story is based on materials provided by University of British Columbia. Note: Materials may be edited for content and length.


Cite This Page:

University of British Columbia. "Largest Review Of Its Kind Associates Anti-inflammatory Drugs With Reduced Breast Cancer Risk." ScienceDaily. ScienceDaily, 8 October 2008. <www.sciencedaily.com/releases/2008/10/081007172858.htm>.
University of British Columbia. (2008, October 8). Largest Review Of Its Kind Associates Anti-inflammatory Drugs With Reduced Breast Cancer Risk. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/10/081007172858.htm
University of British Columbia. "Largest Review Of Its Kind Associates Anti-inflammatory Drugs With Reduced Breast Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/2008/10/081007172858.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins